Growth Metrics

Omeros (OMER) Interest Coverage Ratio Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 79.36%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 29.25%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -16.86%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.78%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 40.09%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn 13.09%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.09%
Dec 31, 2025 13.10%
Sep 30, 2025 29.90%
Jun 30, 2025 -557.21%
Mar 31, 2025 -10.50%
Dec 31, 2024 -6.62%
Sep 30, 2024 -2.52%
Jun 30, 2024 11.59%
Mar 31, 2024 19.96%
Dec 31, 2023 -9.97%
Sep 30, 2023 -18.08%
Jun 30, 2023 -3.65%
Mar 31, 2023 -3.92%
Dec 31, 2022 -7.58%
Sep 30, 2022 -74.34%
Jun 30, 2022 -65.09%
Mar 31, 2022 -27.33%
Dec 31, 2021 -34.15%
Sep 30, 2021 -1.74%
Jun 30, 2021 -3.70%
Mar 31, 2021 1.92%
Dec 31, 2020 4.95%
Sep 30, 2020 -26.20%
Jun 30, 2020 -1.83%
Mar 31, 2020 5.67%
Dec 31, 2019 5.51%
Sep 30, 2019 29.90%
Jun 30, 2019 34.04%
Mar 31, 2019 37.61%
Dec 31, 2018 45.63%
Sep 30, 2018 29.69%
Jun 30, 2018 21.23%
Mar 31, 2018 19.42%
Dec 31, 2017 39.10%
Sep 30, 2017 53.39%
Jun 30, 2017 37.93%
Mar 31, 2017 41.06%
Dec 31, 2016 40.75%
Sep 30, 2016 37.13%
Jun 30, 2016 35.90%
Mar 31, 2016 6.07%
Dec 31, 2015 -3.03%
Sep 30, 2015 11.12%
Jun 30, 2015 2.17%
Mar 31, 2015 -4.67%
Dec 31, 2014 -5.92%
Sep 30, 2014 -15.84%
Jun 30, 2014 -24.99%
Mar 31, 2014 -1.97%
Dec 31, 2013 5.36%
Sep 30, 2013 -3.13%
Jun 30, 2013 -6.18%